News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
FDA
Vacci-Test Corporation Release: European Approval of VACCI-TEST(TM) Tetanus
June 10, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
CALGARY, ALBERTA--(Marketwire - June 10, 2008) - Vacci-Test Corporation ("VTC") of Calgary, Alberta, Canada is pleased to announce that its subsidiary, Vacci-Test Europe, has received the CE mark for its first product, VACCI-TEST™ Tetanus.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
MORE ON THIS TOPIC
Immunology and inflammation
Following Rejection, FDA Okays Sanofi/Regeneron’s Dupixent for Chronic Hives
April 21, 2025
·
2 min read
·
Tristan Manalac
FDA
Makary Discusses Expedited Rare Disease Approvals Pathway, ‘Public Distrust’ in New Interview
April 21, 2025
·
2 min read
·
Tristan Manalac
FDA
FDA’s User Fee Negotiation Teams Gutted by Layoffs: Reuters
April 18, 2025
·
2 min read
·
Tristan Manalac
FDA
FDA Moves to Restrict Industry Influence on Advisory Committees
April 18, 2025
·
2 min read
·
Tristan Manalac